31 Jan, 2019 01:17 PM
SUDA Pharmaceuticals Ltd (ASX: SUD), a leader in oro-mucosal drug delivery, today released its Appendix 4C for the consolidated Group for the second quarter of FY2019.
For more information, dow...read more
29 Jan, 2019 02:51 PM
29th January 2019, SomnoMed Limited (ASX:SOM) announced that its core revenues grew by 13% in the second quarter compared to the prior year, reaching $15.675 million for the three months period. All r...read more
25 Jan, 2019 10:41 AM
Highlights
AusCann completes acquisition of R&D facility in Perth, Western Australia to further develop its cannabinoid pharmaceutical product pipeline.
Site to be state of the art, fully ...read more